Showing results (1-10 of 191) with videos related to
Sort By:
Pageof 20
Clinical and Laboratory Haematology|May 19, 2006
Accelerated hepatitis C virus replication with rituximab treatment in a non-Hodgkin's lymphoma patientS Aksoy, H Abali, S Kilickap, et al.Dermatology (Basel, Switzerland)|January 1, 1996
Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behçet's diseaseM Calgüneri, I Ertenli, S Kiraz, et al.Cancer Investigation|June 17, 1998
Treatment of advanced refractory sarcomas with ifosfamide and etoposide combination chemotherapyS Yalçin, I Güllü, I Barişta, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|December 18, 2013
Increasing performance of a hospital-based cancer registry: Hacettepe University hospitals experienceT Kutluk, K Mutlu Hayran, S Kilickap, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2004
Tamoxifen-induced tissue factor pathway inhibitor reduction: a clue for an acquired thrombophilic state?M Erman, H Abali, B Oran, et al.Clinical and Experimental Rheumatology|January 5, 2002
Synovial fluid cytokine levels in Behçet's diseaseI Ertenli, S Kiraz, M Calgüneri, et al.Clinical and Experimental Rheumatology|January 5, 2002
Interactions of nitric oxide and superoxide dismutase in Behçet's diseaseS Kiraz, I Ertenli, M Calgüneri, et al.Cancer Investigation|January 1, 1996
High-dose ifosfamide by infusion with Mesna in advanced refractory sarcomasI Güllü, S Yalçin, G Tekuzman, et al.Journal of Chemotherapy (Florence, Italy)|August 1, 1996
Ifosfamide, mesna and epirubicin as second-line chemotherapy in advanced breast cancerS Kiraz, E Baltali, N Güler, et al.Tumori|July 1, 1995
Non-Hodgkin's lymphomas of the tonsil: a retrospective analysis of twenty-eight patients with primary tonsillary lymphomaI Barişta, G Tekuzman, I Güllü, et al.Pageof 20